文献速递糖尿病

糖尿病与血液系统恶性肿瘤的关联:基于人群的研究

Association between diabetes and haematological malignancies: a population-based study.
PubMed 文献 · Diabetologia · 2021-01-06

该研究基于加拿大安大略省医疗数据库,纳入1996至2015年间30岁以上无癌症和糖尿病的居民,匹配比较糖尿病患者与非糖尿病者的血液系统恶性肿瘤风险及死亡率。结果显示糖尿病患者发生血液系统恶性肿瘤的风险轻度但显著升高(调整HR 1.10,95%CI 1.08-1.12,p<0.0001),且合并血液系统恶性肿瘤时全因死亡率更高(HR 1.36,95%CI 1.31-1.41,p<0.0001)。

要点

  • 糖尿病患者血液系统恶性肿瘤风险轻度升高(调整HR 1.10)。
  • 该关联在糖尿病诊断后各时间段均持续存在。
  • 合并血液系统恶性肿瘤的糖尿病患者全因死亡率显著增高。

核心结论

  • 糖尿病与血液系统恶性肿瘤风险升高相关,并且是全因死亡和病因特异性死亡的独立危险因素。

研究设计与样本

  • 基于加拿大安大略省医疗数据库的人群基础观察性研究,纳入1996年1月1日至2015年12月31日期间30岁及以上无癌症和糖尿病的居民,采用Cox回归分析。
  • 共识别1,003,276例糖尿病患者,并按年龄和性别匹配2,006,552例非糖尿病个体。

主要发现

  • 糖尿病患者发生血液系统恶性肿瘤的风险较非糖尿病个体轻度但显著升高(调整HR 1.10,95%CI 1.08-1.12,p<0.0001)。
  • 该关联在糖尿病诊断后各时间段(<3个月、3个月至1年、≥1年)均持续存在。
  • 在血液系统恶性肿瘤患者中,糖尿病与更高的全因死亡率相关(HR 1.36,95%CI 1.31-1.41,p<0.0001),并与病因特异性死亡率相关。

临床怎么用

  • 对于糖尿病患者,除关注代谢控制外,应意识到其血液系统恶性肿瘤风险可能轻度增加。
  • 糖尿病患者若合并血液系统恶性肿瘤,需注意其死亡风险更高,应加强综合管理。
  • 加强生活方式干预可能不仅减轻糖尿病负担及其并发症,还可能降低恶性肿瘤和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Contemporary data for the association of diabetes with haematological malignancies are lacking. We evaluated the risk of developing haematological malignancies and subsequent mortality in individuals with diabetes compared with those without diabetes. METHODS: We conducted a population-based observational study using healthcare databases from Ontario, Canada. All Ontario residents 30 years of age or older free of cancer and diabetes between 1 January 1996 and 31 December 2015 were eligible for inclusion. Using Cox regression analyses, we explored the association between diabetes and the risk and mortality of haematological malignancies (leukaemia, lymphoma, multiple myeloma). The impact of timing on associations was evaluated with analyses stratified by time since diabetes diagnosis (<3 months, 3 months to 1 year, ≥1 year). RESULTS: We identified 1,003,276 individuals with diabetes and age and sex matched these to 2,006,552 individuals without diabetes. Compared with individuals without diabetes, those with diabetes had a modest but significantly higher risk of a haematological malignancy (adjusted HR 1.10 [95% CI 1.08, 1.12] p < 0.0001). This association persisted across all time periods since diabetes diagnosis. Among those with haematological malignancies, diabetes was associated with a higher all-cause mortality (HR 1.36 [95% CI 1.31, 1.41] p < 0.0001) compared with no diabetes, as well as cause-specific mortality. CONCLUSIONS/INTERPRETATION: Diabetes is associated with a higher risk of haematological malignancies and is an independent risk factor of all-cause and cause-specific mortality. Greater efforts for lifestyle modification may not only reduce diabetes burden and its complications but may also potentially lower risk of malignancy and mortality. Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Gong IY, Cheung MC, Read S, et al. Association between diabetes and haematological malignancies: a population-based study. Diabetologia. 2021. PMID: 33409570. doi:10.1007/s00125-020-05338-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。